Press release
August 16, 2021
Immunicom Continues Successful Immunopheresis® Clinical Trial in Advanced, Non-Small Cell Lung Cancer Treatment with Acibadem University
July 20, 2021
Immunicom’s Data at ASCO Expand on the Antitumor Activity of its Novel Non-Pharmaceutical Immunotherapy in Late-Stage Breast Cancer Patients
June 23, 2021
Immunicom Presentation Defines Breakthrough Subtractive Therapy’s Role in “New Era” Cancer Care at LSI’s Annual Emerging MedTech Summit
June 10, 2021
Immunicom Presents Promising Clinical Trial Data at AACR in Late-Stage Breast Cancer Patients Treated with Novel Non-Pharmaceutical Immunotherapy
April 30, 2021